TY - JOUR T1 - Heterogeneity in COVID-19 Pandemic-Induced Lifestyle Stressors and Predicts Future Mental Health in Adults and Children in the US and UK JF - medRxiv DO - 10.1101/2021.08.10.21261860 SP - 2021.08.10.21261860 AU - Aki Nikolaidis AU - Jacob DeRosa AU - Mirelle Kass AU - Irene Droney AU - Lindsay Alexander AU - Adriana Di Martino AU - Evelyn Bromet AU - Kathleen Merikangas AU - Michael Peter Milham AU - Diana Paksarian Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/11/2021.08.10.21261860.abstract N2 - Identifying predictors of mental health symptoms after the initial phase of the pandemic may inform the development of targeted interventions to reduce its negative long-term mental health consequences. In the current study, we aimed to simultaneously evaluate the prospective influence of life change stress, personal COVID-19 impact, prior mental health, worry about COVID-19, state-level indicators of pandemic threat, and socio-demographic factors on mood and anxiety symptoms in November 2020 among adults and children in the US and UK. We used a longitudinal cohort study using the Coronavirus Health Impact Survey (CRISIS) collected at 3 time points: an initial assessment in April 2020 (“April”), a reassessment 3 weeks later (“May”), and a 7-month follow-up in November 2020 (“November”). Online surveys were collected in the United States and United Kingdom by Prolific Academic, a survey recruitment service, with a final sample of 859 Adults and 780 children (collected via parent report). We found subtypes of pandemic-related life change stress in social and economic domains derived through Louvain Community Detection. We assessed recalled mood and perceived mental health prior to the pandemic; worries about COVID-19; personal and family impacts of COVID-19; and socio-demographic characteristics. Levels of mood symptoms in November 2020 measured with the circumplex model of affect. We found 3 life change stress subtypes among adults and children: Lower Social/Lower Economic (adults and children), Higher Social/Higher Economic (adults and children), Lower Social/Higher Economic (adults), and Intermediate Social/Lower Economic (children). Overall, mood symptoms decreased between April and November 2020, but shifting from lower to higher-stress subtypes between time points was associated with increasing symptoms. For both adults and children, the most informative predictors of mood symptoms in November identified by conditional random forest models were prior mood and perceived mental health, worries about COVID, and sources of life change. The relative importance of these predictors was the most prominent difference in findings between adults and children, with lifestyle changes stress regarding friendships being more predictive of mood outcomes than worries about COVID in children. In the US, objective state-level indicators of COVID-19 threat were less predictive of November mood than these other predictors. We found that in addition to the well-established influences of prior mood and worry, heterogeneous subtypes of pandemic-related stress were differentially associated with mood after the initial phase of the pandemic. Greater research on diverse patterns of pandemic experience may elucidate modifiable targets for treatment and prevention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAN is funded by a NARSAD Young Investigator grant and NIMH grant R21 MH118556-01. This study was funded in part by the financial firm Morgan Stanley. Drs. Paksarian and Merikangas are supported by the Intramural Research Program of the National Institute of Mental Health (ZIA MH002953).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Exemption from IRB oversight was approved by the Advarra Institutional Review Board. PA participants were required to agree to PAs Terms of Service notification (https://prolific.ac/assets/docs/Participant_Terms.pdf) to complete surveys. Per the IRB exemption, no additional informed consent was required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData has been made publicly available for download here: http://www.crisissurvey.org/ ER -